Research Projects

Exploiting SR-B1 for the development of new immunomodulatory drugs to enhance cancer immunotherapy


Project information

  • Convocation: Health R&D Projects. AES 2016
  • Reference: PI16/00668
  • Duration: 3 years
  • Start date: January 1, 2017
  • End date: December 31, 2019
  • Funder: Instituto de Salud Carlos III y cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER) “Una manera de hacer Europa”
  • Nature of project: National

Need more information?

If you are interested in learning more about our research, please contact us.